Home
EN / FR

Celyad Oncology

Home / Investors / Shareholders Information

Shareholders Information

Shareholders Information

Equity Threshold (as of January 8, 2021)

feb8equity

Voting Threshold (as of January 8, 2021)

feb8voting

Total Number of Shares And Voting Rights

Total amount of share capital (EUR) (as of Jan 8th, 2021) 49,427,200.33
Total number of shares with single voting rights (as of Jan 8th, 2021) 14,132,832
Total number of shares with double voting rights (as of Jan 8th, 2021) 72,324
Total number of shares (as of Jan 8th, 2021) 14,205,156
Total number of voting rights (as of Jan 8th, 2021) 14,277,480
Total number of attributed warrants (as of Jan 8th, 2021) 1,488,06
Total number of shares with voting rights that could be created following the exercise of the attributed warrants (as of Jan 8th, 2021) 1,488,06
Total number of diluted shares (outstanding shares + warrants) (as of Jan 8th, 2021) 15,693,162
Total number of diluted shares with voting rights (as of Jan 8th, 2021) 15,765,486

Transparency Declarations

28 Sep 2018 Victory Capital Management Inc.
01 Jun 2018 Tolefi SA
17 Feb 2017 Tolefi SA
03 Aug 2016 Medisun International Ltd and National Fund Ltd
29 Jun 2015 PMV-TINA
29 Jun 2015 SRIW SA
05 Mar 2015 Tolefi SA
20 Aug 2014 Tolefi SA
12 Jul 2013 Tolefi SA, PMV NV, SRIW SA/ Sofipole SA, Mayo Foundation

Investor Contact Information:

Sara Zelkovic

Communications and IR Director

Investors@celyad.com